Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation

Aims Left atrial catheter ablation of the pulmonary veins (PV) has evolved as an important therapeutic option for the treatment of atrial fibrillation (AF). We aimed to investigate the incidence and predictors of silent cerebral embolism associated with PV catheter ablation, detected by diffusion-we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Europace (London, England) England), 2010-01, Vol.12 (1), p.52-57
Hauptverfasser: Schrickel, Jan Wilko, Lickfett, Lars, Lewalter, Thorsten, Mittman-Braun, Erica, Selbach, Stephanie, Strach, Katharina, Nähle, Claas P., Schwab, Jörg Otto, Linhart, Markus, Andrié, Rene, Nickenig, Georg, Sommer, Torsten
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 57
container_issue 1
container_start_page 52
container_title Europace (London, England)
container_volume 12
creator Schrickel, Jan Wilko
Lickfett, Lars
Lewalter, Thorsten
Mittman-Braun, Erica
Selbach, Stephanie
Strach, Katharina
Nähle, Claas P.
Schwab, Jörg Otto
Linhart, Markus
Andrié, Rene
Nickenig, Georg
Sommer, Torsten
description Aims Left atrial catheter ablation of the pulmonary veins (PV) has evolved as an important therapeutic option for the treatment of atrial fibrillation (AF). We aimed to investigate the incidence and predictors of silent cerebral embolism associated with PV catheter ablation, detected by diffusion-weighted magnetic resonance imaging (DW-MRI). Methods and results We performed a prospective analysis of 53 consecutive patients with persistent or paroxysmal AF that underwent PV ablation and post-procedural cerebral MRI 1 day after lasso catheter-guided ostial PV ablation. Patients were analysed for possible demographical, medical, echocardiographical, and procedural predictors of embolic events. A mean of 3.5 ± 0.5 PVs were ablated per patient. In six patients, DW-MRI depicted new clinically silent microembolism after PV ablation (11%). The number of ineffective medical antiarrhythmic agents prior to ablation procedure was significantly higher in the embolism group (3.3 ± 0.5 vs. 2.2 ± 1.4, P = 0.014). Coronary heart disease (CAD) was more frequent in patients with cerebral embolisms (33 vs. 2%, P = 0.031); left ventricular volume (130 ± 12 vs. 103 ± 26 mL, P = 0.002), and septal wall thickness (13.0 ± 1.4 vs. 7.9 ± 4.8 mm, P = 0.025) were significantly increased. Conclusion This study shows a high incidence of silent micro-embolic events after PV ablation. CAD, left ventricular dilatation, and hypertrophy were potential predictors of this complication.
doi_str_mv 10.1093/europace/eup350
format Article
fullrecord <record><control><sourceid>proquest_TOX</sourceid><recordid>TN_cdi_proquest_miscellaneous_734194760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/europace/eup350</oup_id><sourcerecordid>734194760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-41f5b783b1f03b231772efa47dfb0e30975620f00c72cc16558bd728d0af34933</originalsourceid><addsrcrecordid>eNqFkc1rFjEQxoMotlbPvUluFmHtJNm82RxLqVooeNHzkmQnbWQ3WZOs4H_flH3FWz3NB795mJmHkHMGnxhocYlbTqtx2JJVSHhBTpkUvOOg-cuWg9adZFyfkDel_AQAxbV8TU6Y1kJIpk5JvY0uTBgdUhMnumacgqspF5o8LWHGWKnDjDabmeJi0xzKQqcth3hP121eUjT5D_2NIVJn6gNWzNTY2dSQIvWpFTWHNuuDzWHe-2_JK2_mgu-O8Yz8-Hzz_fprd_fty-311V3nesVq1zMvrRqEZR6E5YIpxdGbXk3eAgrQSh44eACnuHPsIOVgJ8WHCYwXfbvwjHzYddecfm1Y6riE4rBtETFtZVSiZ7pXB2jkxbMk6_VhGFSvZUMvd9TlVEpGP645LO0JI4PxyZTxrynjbkqbeH8U3-yC0z_-6EIDPu5A2tb_qj0CdSKbZg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1496887495</pqid></control><display><type>article</type><title>Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation</title><source>Oxford Journals Open Access Collection</source><creator>Schrickel, Jan Wilko ; Lickfett, Lars ; Lewalter, Thorsten ; Mittman-Braun, Erica ; Selbach, Stephanie ; Strach, Katharina ; Nähle, Claas P. ; Schwab, Jörg Otto ; Linhart, Markus ; Andrié, Rene ; Nickenig, Georg ; Sommer, Torsten</creator><creatorcontrib>Schrickel, Jan Wilko ; Lickfett, Lars ; Lewalter, Thorsten ; Mittman-Braun, Erica ; Selbach, Stephanie ; Strach, Katharina ; Nähle, Claas P. ; Schwab, Jörg Otto ; Linhart, Markus ; Andrié, Rene ; Nickenig, Georg ; Sommer, Torsten</creatorcontrib><description>Aims Left atrial catheter ablation of the pulmonary veins (PV) has evolved as an important therapeutic option for the treatment of atrial fibrillation (AF). We aimed to investigate the incidence and predictors of silent cerebral embolism associated with PV catheter ablation, detected by diffusion-weighted magnetic resonance imaging (DW-MRI). Methods and results We performed a prospective analysis of 53 consecutive patients with persistent or paroxysmal AF that underwent PV ablation and post-procedural cerebral MRI 1 day after lasso catheter-guided ostial PV ablation. Patients were analysed for possible demographical, medical, echocardiographical, and procedural predictors of embolic events. A mean of 3.5 ± 0.5 PVs were ablated per patient. In six patients, DW-MRI depicted new clinically silent microembolism after PV ablation (11%). The number of ineffective medical antiarrhythmic agents prior to ablation procedure was significantly higher in the embolism group (3.3 ± 0.5 vs. 2.2 ± 1.4, P = 0.014). Coronary heart disease (CAD) was more frequent in patients with cerebral embolisms (33 vs. 2%, P = 0.031); left ventricular volume (130 ± 12 vs. 103 ± 26 mL, P = 0.002), and septal wall thickness (13.0 ± 1.4 vs. 7.9 ± 4.8 mm, P = 0.025) were significantly increased. Conclusion This study shows a high incidence of silent micro-embolic events after PV ablation. CAD, left ventricular dilatation, and hypertrophy were potential predictors of this complication.</description><identifier>ISSN: 1099-5129</identifier><identifier>EISSN: 1532-2092</identifier><identifier>DOI: 10.1093/europace/eup350</identifier><identifier>PMID: 19933517</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Antiarrhythmic agents ; Atrial Fibrillation - epidemiology ; Atrial Fibrillation - surgery ; Catheter Ablation - utilization ; Comorbidity ; Female ; Germany - epidemiology ; Humans ; Incidence ; Intracranial Embolism - epidemiology ; Magnetic Resonance Imaging - statistics &amp; numerical data ; Male ; Middle Aged ; Pulmonary Veins - surgery ; Risk Assessment - methods ; Risk Factors</subject><ispartof>Europace (London, England), 2010-01, Vol.12 (1), p.52-57</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org. 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-41f5b783b1f03b231772efa47dfb0e30975620f00c72cc16558bd728d0af34933</citedby><cites>FETCH-LOGICAL-c471t-41f5b783b1f03b231772efa47dfb0e30975620f00c72cc16558bd728d0af34933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1599,27905,27906</link.rule.ids><linktorsrc>$$Uhttps://dx.doi.org/10.1093/europace/eup350$$EView_record_in_Oxford_University_Press$$FView_record_in_$$GOxford_University_Press</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19933517$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schrickel, Jan Wilko</creatorcontrib><creatorcontrib>Lickfett, Lars</creatorcontrib><creatorcontrib>Lewalter, Thorsten</creatorcontrib><creatorcontrib>Mittman-Braun, Erica</creatorcontrib><creatorcontrib>Selbach, Stephanie</creatorcontrib><creatorcontrib>Strach, Katharina</creatorcontrib><creatorcontrib>Nähle, Claas P.</creatorcontrib><creatorcontrib>Schwab, Jörg Otto</creatorcontrib><creatorcontrib>Linhart, Markus</creatorcontrib><creatorcontrib>Andrié, Rene</creatorcontrib><creatorcontrib>Nickenig, Georg</creatorcontrib><creatorcontrib>Sommer, Torsten</creatorcontrib><title>Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation</title><title>Europace (London, England)</title><addtitle>Europace</addtitle><description>Aims Left atrial catheter ablation of the pulmonary veins (PV) has evolved as an important therapeutic option for the treatment of atrial fibrillation (AF). We aimed to investigate the incidence and predictors of silent cerebral embolism associated with PV catheter ablation, detected by diffusion-weighted magnetic resonance imaging (DW-MRI). Methods and results We performed a prospective analysis of 53 consecutive patients with persistent or paroxysmal AF that underwent PV ablation and post-procedural cerebral MRI 1 day after lasso catheter-guided ostial PV ablation. Patients were analysed for possible demographical, medical, echocardiographical, and procedural predictors of embolic events. A mean of 3.5 ± 0.5 PVs were ablated per patient. In six patients, DW-MRI depicted new clinically silent microembolism after PV ablation (11%). The number of ineffective medical antiarrhythmic agents prior to ablation procedure was significantly higher in the embolism group (3.3 ± 0.5 vs. 2.2 ± 1.4, P = 0.014). Coronary heart disease (CAD) was more frequent in patients with cerebral embolisms (33 vs. 2%, P = 0.031); left ventricular volume (130 ± 12 vs. 103 ± 26 mL, P = 0.002), and septal wall thickness (13.0 ± 1.4 vs. 7.9 ± 4.8 mm, P = 0.025) were significantly increased. Conclusion This study shows a high incidence of silent micro-embolic events after PV ablation. CAD, left ventricular dilatation, and hypertrophy were potential predictors of this complication.</description><subject>Antiarrhythmic agents</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Atrial Fibrillation - surgery</subject><subject>Catheter Ablation - utilization</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Germany - epidemiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Intracranial Embolism - epidemiology</subject><subject>Magnetic Resonance Imaging - statistics &amp; numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pulmonary Veins - surgery</subject><subject>Risk Assessment - methods</subject><subject>Risk Factors</subject><issn>1099-5129</issn><issn>1532-2092</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1rFjEQxoMotlbPvUluFmHtJNm82RxLqVooeNHzkmQnbWQ3WZOs4H_flH3FWz3NB795mJmHkHMGnxhocYlbTqtx2JJVSHhBTpkUvOOg-cuWg9adZFyfkDel_AQAxbV8TU6Y1kJIpk5JvY0uTBgdUhMnumacgqspF5o8LWHGWKnDjDabmeJi0xzKQqcth3hP121eUjT5D_2NIVJn6gNWzNTY2dSQIvWpFTWHNuuDzWHe-2_JK2_mgu-O8Yz8-Hzz_fprd_fty-311V3nesVq1zMvrRqEZR6E5YIpxdGbXk3eAgrQSh44eACnuHPsIOVgJ8WHCYwXfbvwjHzYddecfm1Y6riE4rBtETFtZVSiZ7pXB2jkxbMk6_VhGFSvZUMvd9TlVEpGP645LO0JI4PxyZTxrynjbkqbeH8U3-yC0z_-6EIDPu5A2tb_qj0CdSKbZg</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Schrickel, Jan Wilko</creator><creator>Lickfett, Lars</creator><creator>Lewalter, Thorsten</creator><creator>Mittman-Braun, Erica</creator><creator>Selbach, Stephanie</creator><creator>Strach, Katharina</creator><creator>Nähle, Claas P.</creator><creator>Schwab, Jörg Otto</creator><creator>Linhart, Markus</creator><creator>Andrié, Rene</creator><creator>Nickenig, Georg</creator><creator>Sommer, Torsten</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20100101</creationdate><title>Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation</title><author>Schrickel, Jan Wilko ; Lickfett, Lars ; Lewalter, Thorsten ; Mittman-Braun, Erica ; Selbach, Stephanie ; Strach, Katharina ; Nähle, Claas P. ; Schwab, Jörg Otto ; Linhart, Markus ; Andrié, Rene ; Nickenig, Georg ; Sommer, Torsten</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-41f5b783b1f03b231772efa47dfb0e30975620f00c72cc16558bd728d0af34933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antiarrhythmic agents</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Atrial Fibrillation - surgery</topic><topic>Catheter Ablation - utilization</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Germany - epidemiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Intracranial Embolism - epidemiology</topic><topic>Magnetic Resonance Imaging - statistics &amp; numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pulmonary Veins - surgery</topic><topic>Risk Assessment - methods</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schrickel, Jan Wilko</creatorcontrib><creatorcontrib>Lickfett, Lars</creatorcontrib><creatorcontrib>Lewalter, Thorsten</creatorcontrib><creatorcontrib>Mittman-Braun, Erica</creatorcontrib><creatorcontrib>Selbach, Stephanie</creatorcontrib><creatorcontrib>Strach, Katharina</creatorcontrib><creatorcontrib>Nähle, Claas P.</creatorcontrib><creatorcontrib>Schwab, Jörg Otto</creatorcontrib><creatorcontrib>Linhart, Markus</creatorcontrib><creatorcontrib>Andrié, Rene</creatorcontrib><creatorcontrib>Nickenig, Georg</creatorcontrib><creatorcontrib>Sommer, Torsten</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Europace (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Schrickel, Jan Wilko</au><au>Lickfett, Lars</au><au>Lewalter, Thorsten</au><au>Mittman-Braun, Erica</au><au>Selbach, Stephanie</au><au>Strach, Katharina</au><au>Nähle, Claas P.</au><au>Schwab, Jörg Otto</au><au>Linhart, Markus</au><au>Andrié, Rene</au><au>Nickenig, Georg</au><au>Sommer, Torsten</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation</atitle><jtitle>Europace (London, England)</jtitle><addtitle>Europace</addtitle><date>2010-01-01</date><risdate>2010</risdate><volume>12</volume><issue>1</issue><spage>52</spage><epage>57</epage><pages>52-57</pages><issn>1099-5129</issn><eissn>1532-2092</eissn><abstract>Aims Left atrial catheter ablation of the pulmonary veins (PV) has evolved as an important therapeutic option for the treatment of atrial fibrillation (AF). We aimed to investigate the incidence and predictors of silent cerebral embolism associated with PV catheter ablation, detected by diffusion-weighted magnetic resonance imaging (DW-MRI). Methods and results We performed a prospective analysis of 53 consecutive patients with persistent or paroxysmal AF that underwent PV ablation and post-procedural cerebral MRI 1 day after lasso catheter-guided ostial PV ablation. Patients were analysed for possible demographical, medical, echocardiographical, and procedural predictors of embolic events. A mean of 3.5 ± 0.5 PVs were ablated per patient. In six patients, DW-MRI depicted new clinically silent microembolism after PV ablation (11%). The number of ineffective medical antiarrhythmic agents prior to ablation procedure was significantly higher in the embolism group (3.3 ± 0.5 vs. 2.2 ± 1.4, P = 0.014). Coronary heart disease (CAD) was more frequent in patients with cerebral embolisms (33 vs. 2%, P = 0.031); left ventricular volume (130 ± 12 vs. 103 ± 26 mL, P = 0.002), and septal wall thickness (13.0 ± 1.4 vs. 7.9 ± 4.8 mm, P = 0.025) were significantly increased. Conclusion This study shows a high incidence of silent micro-embolic events after PV ablation. CAD, left ventricular dilatation, and hypertrophy were potential predictors of this complication.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>19933517</pmid><doi>10.1093/europace/eup350</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1099-5129
ispartof Europace (London, England), 2010-01, Vol.12 (1), p.52-57
issn 1099-5129
1532-2092
language eng
recordid cdi_proquest_miscellaneous_734194760
source Oxford Journals Open Access Collection
subjects Antiarrhythmic agents
Atrial Fibrillation - epidemiology
Atrial Fibrillation - surgery
Catheter Ablation - utilization
Comorbidity
Female
Germany - epidemiology
Humans
Incidence
Intracranial Embolism - epidemiology
Magnetic Resonance Imaging - statistics & numerical data
Male
Middle Aged
Pulmonary Veins - surgery
Risk Assessment - methods
Risk Factors
title Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T07%3A33%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_TOX&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20predictors%20of%20silent%20cerebral%20embolism%20during%20pulmonary%20vein%20catheter%20ablation%20for%20atrial%20fibrillation&rft.jtitle=Europace%20(London,%20England)&rft.au=Schrickel,%20Jan%20Wilko&rft.date=2010-01-01&rft.volume=12&rft.issue=1&rft.spage=52&rft.epage=57&rft.pages=52-57&rft.issn=1099-5129&rft.eissn=1532-2092&rft_id=info:doi/10.1093/europace/eup350&rft_dat=%3Cproquest_TOX%3E734194760%3C/proquest_TOX%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1496887495&rft_id=info:pmid/19933517&rft_oup_id=10.1093/europace/eup350&rfr_iscdi=true